FilingIndex
6-KThe Wire

TAKEDA PHARMACEUTICAL CO LTD files 6-K

Filed May 13, 2026 · 1mo ago · Accession 0001395064-26-000147

Plain English

Takeda Pharmaceutical Company Limited is filing a Form 6-K to provide information regarding its Stock Compensation Plan for Directors and Stock Grant System for Company Management in Japan for 2026. This filing does not contain financial results.

Read the original on SEC.gov ↗
Filing details
Ticker
TAK
CIK
1395064
Form type
6-K
Filing date
May 13, 2026
Report date
May 13, 2026
Document
form6k-2_051326.htm
Size
2.6 MB